Document Detail

Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.
MedLine Citation:
PMID:  22720749     Owner:  NLM     Status:  MEDLINE    
Glioblastoma (GBM) developed metastases rarely and the prognosis, in these cases, was very poor. We reported a 30-year patient who, developing intramedullary and leptomeningeal metastases from GBM, underwent palliative spinal radiotherapy (RT) and Bevacizumab.
Alba Fiorentino; Rocchina Caivano; Costanza Chiumento; Mariella Cozzolino; Vincenzo Fusco
Related Documents :
22760539 - Rib osteomyelitis in a pediatric patient case report and literature review.
22742449 - Spontaneous closure of stage iv idiopathic full-thickness macular hole and late reopeni...
16973099 - Severe domestic squalor: a review.
22365919 - Cullen's sign - case report with a review of the literature.
24412769 - A case report and review of the literature: floating aortic thrombus.
22965219 - An incidental finding of an intraosseous metallic object within the os calcis.
439319 - Heparin-induced spinal fractures.
20935619 - Content development for european guidelines on the use of opioids for cancer pain: a sy...
19920889 - Pharmaco-management of inhalation injuries for burn survivors.
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2012-08-08
Journal Detail:
Title:  The International journal of neuroscience     Volume:  122     ISSN:  1563-5279     ISO Abbreviation:  Int. J. Neurosci.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-12     Completed Date:  2013-03-19     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  0270707     Medline TA:  Int J Neurosci     Country:  England    
Other Details:
Languages:  eng     Pagination:  691-4     Citation Subset:  IM    
Department of Radiotherapy Oncology, IRCCS/CROB, Rionero in Vulture (PZ), Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inhibitors / administration & dosage
Antibodies, Monoclonal, Humanized / administration & dosage*
Brain Neoplasms / pathology,  surgery,  therapy*
Chemoradiotherapy / methods*
Glioblastoma / secondary,  surgery,  therapy*
Meningeal Neoplasms / secondary,  surgery,  therapy*
Spinal Cord Neoplasms / secondary,  surgery,  therapy*
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal, Humanized; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Kenyan newspaper analysis of the limitations of voluntary medical male circumcision and the import...
Next Document:  Striga parasitizes transgenic hairy roots of Zea mays and provides a tool for studying plant-plant i...